MoneyWorks4Me

The company witnessed a 15.55% growth in the revenue at Rs. 26600.00 millions for the quarter ended September 2025 as compared to Rs. 23020.00 millions during the year-ago period.A good growth in profit of 34.36% reported to Rs. 6960.00  millions over Rs. 5180.00 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 10410.00 millions from 8340.00 millions in the quarter ended September 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 26600.00 23020.00 15.55 50170.00 43650.00 14.94 91980.00 76650.00 20.00
Other Income 1460.00 1050.00 39.05 2650.00 1840.00 44.02 3520.00 3370.00 4.45
PBIDT 10410.00 8340.00 24.82 19030.00 15340.00 24.05 33310.00 25110.00 32.66
Interest 80.00 10.00 700.00 110.00 10.00 1000.00 10.00 30.00 -66.67
PBDT 10330.00 8330.00 24.01 18920.00 15330.00 23.42 33300.00 25080.00 32.78
Depreciation 1130.00 980.00 15.31 2250.00 1950.00 15.38 4010.00 3760.00 6.65
PBT 9200.00 7350.00 25.17 16670.00 13380.00 24.59 29290.00 21320.00 37.38
TAX 2240.00 2170.00 3.23 4140.00 3900.00 6.15 7200.00 5560.00 29.50
Deferred Tax 40.00 -10.00 -500.00 30.00 -60.00 -150.00 -730.00 450.00 -262.22
PAT 6960.00 5180.00 34.36 12530.00 9480.00 32.17 22090.00 15760.00 40.16
Equity 530.00 530.00 0.00 530.00 530.00 0.00 530.00 530.00 0.00
PBIDTM(%) 39.14 36.23 8.02 37.93 35.14 7.93 36.21 32.76 10.55
Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..